Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-045396
Date:2019-08-08
Issuer: PORTOLA PHARMACEUTICALS INC (PTLA)
Original Submission Date:

Reporting Person:

RENTON HOLLINGS
C/O PORTOLA PHARMACEUTICALS, INC.
270 EAST GRAND AVE. SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-08-08 M 5,000 a $9.00 18,194 direct
COMMON STOCK 2019-08-08 S 5,000 d $30.00 13,194 direct
COMMON STOCK 2019-08-08 0 $0.00 2,826 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS (RIGHT TO BUY) 9.0 2019-08-08 deemed execution date M 5,000 (d) 2020-04-27 common stock 5,000 $9.00 10,000 direct
Footnotes
IDfootnote
f1 the sale reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 13, 2019.
f2 the option, representing a right to purchase a total of 20,000 shares, became exercisable monthly over a two year period beginning on may 29, 2010.
WhaleWisdom Logo

Elevate your investments